DC
NEXI

Davenport & Co’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Davenport & Co’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,040
Closed -$7.33K – 1099
2023
Q2 		$7.33K Buy
1,040
+320
+44% +$2.76K ﹤0.01% 1050
2023
Q1 		$6.84K Buy
720
+300
+71% +$3.15K ﹤0.01% 1036
2022
Q4 		$2.55K Hold
420
– – ﹤0.01% 1002
2022
Q3 		$6K Buy
+420
New +$12.3K ﹤0.01% 990

Other funds holding NEXI

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Davenport & Co's NEXI Position: Q3 2023 in Review

Davenport & Co sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2023, closing a stake of 1,040 shares — an estimated $7.33K sold.

Davenport & Co first reported a position in NEXI in Q3 2022 and held it in 4 quarters. The position peaked at $7.33K in Q2 2023. 30 funds tracked by Wall St. Rank hold NEXI as of Q3 2023.

  • Davenport & Co reported no remaining NexImmune, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Davenport & Co sold 1,040 NexImmune, Inc. Common Stock shares in Q3 2023, an estimated $7.33K.
  • Davenport & Co first reported a position in NexImmune, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Davenport & Co's NexImmune, Inc. Common Stock position peaked at $7.33K in Q2 2023.
  • 30 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2023.

Based on Davenport & Co's 13F filing for Q3 2023, filed 17 Oct 2023.